Effectiveness of vasoactive correction and post-ischemic swelling in treatment of facial nerve neuropathy: possibility of using L-lysine escinate drug
The article shows the effectiveness of the complex therapy of patients with FNN with the inclusion venomotor and angioprotective preparation of L-lysine aescinat. The purpose of the study - assessment of the effectiveness of the drug L-lysine estsinalv FNN complex therapy of various origins in the acute period. Materials and methods. We observed 60 patients aged 20 to 70 years with the diagnosis of «facial nerve neuropathy,» the acute phase. The main group of patients along with standard treatment regimens received L-lysine aescinat 5.0 ml intravenously for 10 days. The effectiveness of treatment was assessed by a specialized clinical neurological examination (the degree and rate of recovery of motor function using scales K. Rosler and Hause-Brackman, development or absence sinkenezy and contractures), results electroneuromyographic. Results and conclusion. The inclusion of L-lysine aescinat in the complex therapy of patients with acute NFN is pathogenetically justified and can achieve significant efficiency gains by improving microcirculation, reducing the severity of edema syndrome, inflammation and high-quality regeneration. There was the M-response amplitude of the greatest gain after treatment; reduced starting date of the recovery processes and complete recovery.